Sleep Apnea News and Research

RSS

Study finds 18% of pediatric patients at-risk for sleep-related breathing disorders

According to new research that will be presented on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, an estimated 18 percent of pediatric patients in a University of North Carolina-based study were at-risk for sleep-related breathing disorders (SRBD). Importantly, pediatric risk was not associated with any demographic or craniofacial characteristics, as it is in adults, making it difficult to detect.

5 Jun 2010

Nasendoscopies help predict response to OAT in sleep apnea patients

According to new research that will be presented on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, nasendoscopy may help dentists predict oral appliance therapy success in sleep apnea patients. Nasendoscopy involves a flexible endoscope being inserted through the nasal cavity. The tip of the scope is placed at the level of the velopharynx and oro-/hypopharynx.

5 Jun 2010

New research: Questionnaires can help dentists screen for SDB in pediatric population

According to new research that will receive the Graduate Student Research Award on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, questionnaires can help dentists screen for sleep-disordered breathing in a pediatric population. SDB includes obstructive sleep apnea, upper-airway resistance syndrome, and snoring.

5 Jun 2010

Phase II trial of NUVIGIL Tablets for treatment of schizophrenia fails to meet primary endpoint: Cephalon

Cephalon, Inc. today announced that the primary endpoint was not met in a Phase II clinical trial that examined NUVIGIL (armodafinil) Tablets [C-IV] as an adjunctive therapy for the treatment of the negative symptoms of schizophrenia, which include problems with motivation and emotional withdrawal.

3 Jun 2010

CPAP treatment may be a better option for preterm infants

A national study involving a UT Southwestern Medical Center neonatologist provides new insight into how much oxygen preterm infants should receive as well as the optimal way to deliver it to them.

3 Jun 2010

Phase 3 pivotal REVIVE study data of VIVUS' avanafil for ED presented at 2010 AUA

VIVUS, Inc. today announced that data from the previously reported phase 3 pivotal REVIVE (TA-301) study, evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED), were presented at the American Urological Association (AUA) 2010 Annual Meeting.

2 Jun 2010

Victhom attributes 99.6% decrease in first-quarter revenues to transfer of development activities to Ossur

Victhom Human Bionics Inc. today reported its first quarter 2010 financial results.

29 May 2010

VIVUS to present phase 3 data on avanafil for treatment of ED at AUA 2010

VIVUS, Inc. today announced that phase 3 data on avanafil, a next generation oral phosphodiesterase type 5 inhibitor therapy being investigated for the treatment of erectile dysfunction, will be presented next Tuesday at the American Urological Association 2010 Annual Meeting in San Francisco, California.

28 May 2010

VIVUS first-quarter 2010 total revenues decline: MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring VIVUS Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

28 May 2010

New FDA approved Landon Medical LM-800 Finger Pulse Oximeter available for home use

PulseOximetersDIRECT.com, the leading online retailer of portable Pulse Oximeter products introduces today the new, affordable $39 FDA approved Landon Medical LM-800 Finger Pulse Oximeter for home use.

24 May 2010

Studies show positive effects of CPAP on cardiovascular incidence in non-sleepy OSA patients

In non-sleepy patients with obstructive sleep apnea, treatment with continuous positive airway pressure can reduce the incidence of cardiovascular events and hypertension, according to researchers from Spain.

20 May 2010

Home portable monitor testing can be used to diagnose, manage patients with OSA: Study

Patients with suspected obstructive sleep apnea may no longer have to spend an expensive and uncomfortable night at a sleep center to monitor their sleep-disordered breathing. According to new research, those who performed sleep testing in their home with portable monitors showed similar improvements after three months of treatment with continuous positive airway pressure in daytime function as compared to patients who underwent overnight testing in a sleep center.

20 May 2010

Breathe Technologies to fund commercialization of mobile ventilation system with $23M Series C financing

Breathe Technologies, Inc., a manufacturer of innovative technology solutions for people with respiratory conditions, including chronic obstructive pulmonary disease and sleep apnea, announced today it has secured $23 million in Series C financing.

19 May 2010

Sleep apnea increases insulin resistance: Study

Sleep apnea may cause metabolic changes that increase insulin resistance, according to researchers from the University of Pittsburgh Medical Center. The intermittent hypoxia associated with sleep apnea causes a distinct drop in insulin sensitivity in mice, even though chronic hypoxia, such as that associated with high altitude, did not.

18 May 2010

Apnex HGNS System shows promising results in people suffering from OSA

Apnex Medical announced today that preliminary data from a first-in-man clinical study showed significant improvements in sleep for people suffering from obstructive sleep apnea. The Apnex HGNS™ System, developed by the St. Paul-based company, is a device designed to treat OSA, which is a serious life-threatening illness characterized by fragmented sleep and excessive day-time sleepiness.

18 May 2010

Cortex first-quarter net income increases to $0.08 per share

Cortex Pharmaceuticals, Inc. reported net income of approximately $5,596,000, or $0.08 per share for the quarter ended March 31, 2010 compared with a net loss of $3,168,000, or $0.07 per share for the corresponding prior year period, with the difference reflecting revenues from the Company's March 2010 transaction with Biovail Laboratories International SRL (Biovail).

17 May 2010

Obese patients with COPD improve following pulmonary rehabilitation program: Research

Obese patients with chronic obstructive pulmonary disease stand to gain as much from pulmonary rehabilitation as their slimmer counterparts, even though as a group they have a lower exercise capacity, according to new research from the University Hospitals of Leicester in the UK.

17 May 2010

Sleep Apnea News and Research

Study finds 18% of pediatric patients at-risk for sleep-related breathing disorders

Nasendoscopies help predict response to OAT in sleep apnea patients

New research: Questionnaires can help dentists screen for SDB in pediatric population

Phase II trial of NUVIGIL Tablets for treatment of schizophrenia fails to meet primary endpoint: Cephalon

CPAP treatment may be a better option for preterm infants

Phase 3 pivotal REVIVE study data of VIVUS' avanafil for ED presented at 2010 AUA

Victhom attributes 99.6% decrease in first-quarter revenues to transfer of development activities to Ossur

VIVUS to present phase 3 data on avanafil for treatment of ED at AUA 2010

VIVUS first-quarter 2010 total revenues decline: MicroStockProfit.com

New FDA approved Landon Medical LM-800 Finger Pulse Oximeter available for home use

Studies show positive effects of CPAP on cardiovascular incidence in non-sleepy OSA patients

Home portable monitor testing can be used to diagnose, manage patients with OSA: Study

Breathe Technologies to fund commercialization of mobile ventilation system with $23M Series C financing

Sleep apnea increases insulin resistance: Study

Apnex HGNS System shows promising results in people suffering from OSA

Cortex first-quarter net income increases to $0.08 per share

Obese patients with COPD improve following pulmonary rehabilitation program: Research

Early CPAP as effective for preemies as ventilator, with fewer complications: Study

Data on Qnexa to be presented at World Congress on CODHy in Prague

Graymark Healthcare first-quarter consolidated net revenues increase 7% to $27.6 million

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News